Nika Pharmaceuticals, Inc
NIKA· OTC
NIKANika Pharmaceuticals, Inc
Filed May 15, 2023 · 10-Q · 45 days after period end · 0001826466-23-000022
| Metric | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | — |
| Net Income | $19.57K | -$6.32K | -$5.75K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nika Pharmaceuticals, Inc · CIK 1145604 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 15, 2023 · 45 d after period end
